Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow Quality Index
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Quality Index of 11.05x as of September 2025. Operating cash flow of Rs11.52 Billion exceeds net income of Rs1.04 Billion, indicating high earnings quality where cash backs reported profits. Explore Akums Drugs and Pharmaceutical cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Akums Drugs and Pharmaceutical Cash Flow Quality Index (2023–2026)
Historical Cash Flow Quality Index for Akums Drugs and Pharmaceutical across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see AKUMS cash flow metrics.
Annual Cash Flow Quality Index for Akums Drugs and Pharmaceutical (2023–2026)
Year-by-year earnings quality comparison for Akums Drugs and Pharmaceutical.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 4.74x | Rs12.11 Billion | Rs2.55 Billion | ▲ +252.1% |
| 2025 | 1.35x | Rs4.65 Billion | Rs3.45 Billion | ▲ +14.7% |
| 2023 | 1.18x | Rs1.77 Billion | Rs1.50 Billion | — |